Neural Regeneration Research ›› 2025, Vol. 20 ›› Issue (1): 207-208.doi: 10.4103/NRR.NRR-D-23-01630

Previous Articles     Next Articles

Glial response in the midcingulate cortex in Huntington’s disease

Thulani H. Palpagama, Andrea Kwakowsky*   

  1. Center for Brain Research and Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand (Palpagama TH, Kwakowsky A)
    Pharmacology and Therapeutics, School of Medicine, Galway Neuroscience Center, University of Galway, Galway, Ireland (Kwakowsky A) 
  • Online:2025-01-15 Published:2025-01-15
  • Contact: Andrea Kwakowsky, PhD, andrea.kwakowsky@universityofgalway.ie.

Abstract: Huntington’s disease (HD) is a genetic disease characterized by the progressive degeneration of the striatum and cortex. Patients can present with a variety of symptoms that can broadly be classified into motor symptoms, inclusive of choreatic movements and rigidity, mood and psychiatric symptoms, such as depression and apathy, and cognitive symptoms, such as cognitive decline. The causal mutation underlying HD results from an expansion of a CAG repeat sequence on the IT15 gene, resulting in the formation and accumulation of a mutant huntingtin protein.